EBCC-14 manifesto: Addressing disparities in access to innovation for patients with metastatic breast cancer across Europe.
(2024) European Journal of Cancer — Vol. 207, p. 114156 [1-9] (2024)
Files
2024_Ignatiadis_Eur_J_Cancer.pdf
Open Access - Adobe PDF
- 674.57 KB
Details
- Authors
- Abstract
- The European Breast Cancer Council (EBCC) traditionally identifies controversies or major deficiencies in the management of patients with breast cancer and selects a multidisciplinary expert team to collaborate in setting crucial principles and recommendations to improve breast cancer care. The 2024 EBCC manifesto focuses on disparities in the care of patients with metastatic breast cancer. There are several reasons for existing disparities both between and within countries. Our recommendations aim to address the stigma of metastatic disease, which has led to significant disparities in access to innovative care regardless of the gross national income of a country. These recommendations are for different stakeholders to promote the care of patients with metastatic breast cancer across Europe and worldwide.
- Affiliations
Citations
Ignatiadis, M., Poulakaki, F., Spanic, T., Brain, E., Lacombe, D., Sonke, G. S., Vincent-Salomon, A., Van Duijnhoven, F., Meattini, I., Kaidar-Person, O., Aftimos, P., Lecouvet, F., Cardoso, F., Retèl, V. P., & Cameron, D. (2024). EBCC-14 manifesto: Addressing disparities in access to innovation for patients with metastatic breast cancer across Europe. European Journal of Cancer, 207, 114156 [1-9]. https://doi.org/10.1016/j.ejca.2024.114156 (Original work published 2024)